Cargando…

Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile

Spondyloarthritis is a group of immune-mediated rheumatic disorders that significantly impact patients’ physical function and quality of life. Patients with spondyloarthritis experience a greater prevalence of cardiometabolic disorders, such as obesity, hypertension, dyslipidemia and diabetes mellit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Queiro, Rubén, Aurrecoechea, Elena, Alonso Castro, Sara, Villa Blanco, Ignacio, Brandy-Garcia, Anahy, Linge, Raquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391638/ https://www.ncbi.nlm.nih.gov/pubmed/37533855 http://dx.doi.org/10.3389/fimmu.2023.1203372

Ejemplares similares

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis
por: Wang, Runsheng, et al.
Publicado: (2021)

Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis
por: Queiro, Rubén, et al.
Publicado: (2022)

Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes
por: Alonso-Castro, Sara, et al.
Publicado: (2023)

Interleukin 27 is a novel cytokine with anti-inflammatory effects against spondyloarthritis through the suppression of Th17 responses
por: Jouhault, Quentin, et al.
Publicado: (2023)

Are Patients with Axial Spondyloarthritis Who Were Breastfed Protected against the Development of Severe Disease?
por: Alonso, Sara, et al.
Publicado: (2023)

Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?
por: Queiro-Silva, Rubén, et al.
Publicado: (2021)

The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling
por: van Tok, Melissa N., et al.
Publicado: (2018)

A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis
por: Queiro, Rubén, et al.
Publicado: (2021)

Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis
por: Reinhardt, Annika, et al.
Publicado: (2018)

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status
por: Queiro, Rubén, et al.
Publicado: (2022)

Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis
por: Yeremenko, Nataliya
Publicado: (2021)

Mechanistic rationales for targeting interleukin-17A in spondyloarthritis
por: Raychaudhuri, Siba P., et al.
Publicado: (2017)

Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature
por: Torre-Alonso, Juan Carlos, et al.
Publicado: (2018)

Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?
por: Rosine, Nicolas, et al.
Publicado: (2021)

Commentary: Sex-based medicine in psoriatic arthritis: Lessons learned from machine learning-based prediction models
por: Queiro, Rubén
Publicado: (2022)

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
por: Navarro-Compán, Victoria, et al.
Publicado: (2023)

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
por: Ceribelli, Angela, et al.
Publicado: (2021)

Role of Interleukin-17 in Acute Pancreatitis
por: Li, Guanqun, et al.
Publicado: (2021)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models
por: Mandour, Mohamed, et al.
Publicado: (2021)

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
por: Schön, Michael P., et al.
Publicado: (2018)

Interleukin-17 in Chronic Inflammatory Neurological Diseases
por: Milovanovic, Jelena, et al.
Publicado: (2020)

Genetics and Functional Genomics of Spondyloarthritis
por: Costantino, Félicie, et al.
Publicado: (2018)

Biology of Interleukin-17 and Its Pathophysiological Significance in Sepsis
por: Ge, Yun, et al.
Publicado: (2020)

Interleukin-17A Interweaves the Skeletal and Immune Systems
por: Tang, Mengjia, et al.
Publicado: (2021)

Contribution of Interleukin-17A to Retinal Degenerative Diseases
por: Zhong, Huimin, et al.
Publicado: (2022)

Improving the standard of care for patients with spondyloarthritis-related immune inflammatory conditions: results of a Delphi study and proposal for early detection
por: Coto, Pablo, et al.
Publicado: (2020)

Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis
por: Na, Hyun Sik, et al.
Publicado: (2020)

Corrigendum: Interleukin-1-Interleukin-17 Signaling Axis Induces Cartilage Destruction and Promotes Experimental Osteoarthritis
por: Na, Hyun Sik, et al.
Publicado: (2020)

Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis
por: Tu, Liudan, et al.
Publicado: (2021)

Interleukin-22 Influences the Th1/Th17 Axis
por: Lindahl, Hannes, et al.
Publicado: (2021)

Interleukin-17 as a potential therapeutic target for chronic pain
por: Jiang, Xiaojuan, et al.
Publicado: (2022)

The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors
por: Davydova, Anna, et al.
Publicado: (2023)

Drug Retention Rate and Factors Associated with Discontinuation of Interleukin-17 Inhibitors in Patients with Axial Spondyloarthritis
por: Kwon, Oh Chan, et al.
Publicado: (2023)

Identification of gut dysbiosis in axial spondyloarthritis patients and improvement of experimental ankylosing spondyloarthritis by microbiome-derived butyrate with immune-modulating function
por: Min, Hong Ki, et al.
Publicado: (2023)

Association of circulating calprotectin with lipid profile in axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2018)

TCR repertoire profiling revealed antigen-driven CD8+ T cell clonal groups shared in synovial fluid of patients with spondyloarthritis
por: Komech, Ekaterina A., et al.
Publicado: (2022)

Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis
por: Matthews, Kerryn, et al.
Publicado: (2011)

Autoantibodies in Spondyloarthritis, Focusing on Anti-CD74 Antibodies
por: Liu, Yuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n9na7tgfp9r4215fv2alm4qt6g